Arthropathy in Acromegaly

Rheumatic Disease Clinics of North America

Volumn 36, Issue 4, 2010, Pages 713-720

  Killinger, Z ^a   Payer, J ^a   Lazurova I ^b   Imrich, R ^c   Homerova Z ^a   Kuzma M ^a   Rovensky J ^d,e  

^a UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^b 1st Department of Internal Medicine   (Slovakia)

^c INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^d NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

^e UNIVERSITY OF SS CYRIL AND METHODIUS   (Slovakia)

Author keywords

Arthropathy in acromegaly; Definition; Epidemiology and pathogenesis; Musculoskeletal manifestation; Treatment of acromegaly

Indexed keywords

GROWTH HORMONE; PEGVISOMANT; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ARTHRALGIA; ARTHROPATHY; BONE MASS; CARPAL TUNNEL SYNDROME; EARLY DIAGNOSIS; GROWTH HORMONE RELEASE; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HYPOGONADISM; JOINT SURGERY; MORBIDITY; MORTALITY; MUSCULOSKELETAL PAIN; NERVE DECOMPRESSION; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW;

ACROMEGALY; ARTHRALGIA; COMORBIDITY; FEMALE; HAND JOINTS; HUMANS; JOINT DISEASES; MALE; MUSCLES; MUSCULAR DISEASES; OSTEOPHYTE; PREVALENCE; SLOVAKIA;

EID: 78449269935     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2010.09.004     Document Type: Review

References (16)

1. Biermasz N.R., Pereira A.M., Smit J.W., et al. Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 2005, 90:2731-2739.
2. Wass J.A. Acromegaly: a handbook of history, current therapy and future prospect 2009, Bio Scientific Ltd, p. 43-49.
3. Harris A.G. Acromegaly and its management 1996, Lippincott-Raven, Philadelphia, p. 24-35.
4. Marie P. Sur deux cas d′acromégalie. Rev Med 1886, 6:297-299.
5. Chipman J.J., Attanasio A.F., Birkett M.A., et al. The safety profile of GH replacement therapy in adults. Clin Endocrinol 1997, 46:473-481.
6. Wassenaar M.J., Biermasz N.R., van Diunen N., et al. High prevalnece of artropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study. Eur J Endocrinol 2009, 160:357-365.
7. Podgorski M., Robinson B., Weissberger A., et al. Articular manifestations of acromegaly. Aust N Z J Med 1988, 18:28-35.
8. Biermasz N.R., van Thiel S.W., Pereira A.M., et al. Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 2004, 89:5369-5376.
9. Mestron A., Webb S.M., Astorga R., et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry. Eur J Endocrinol 2004, 151:439-446.
10. Miller A., Doll H., David J., et al. Impact of musculosceletal disease on quality of life in long-standing acromegaly. Eur J Endocrinol 2008, 158:587-593.
11. Kameyama S., Tanaka R., Hasegawa A., et al. Subclinical carpal tunnel syndrome in acromegaly. Neurol Med Chir 1993, 33:547-551.
12. Iwasaki N., Masuko T., Ishikawa J., et al. Surgical efficacy of carpal tunnel release for carpal tunnel syndrome in acromegaly: report of four patients. J Hand Surg 2005, 6:605-606.
13. Giustina A., Mazziotti G., Canalis A. Growth hormone, insulin-like growth factors and the skeleton. Endocr Rev 2008, 29:535-559.
14. Shane E. Osteoporosis associated with illness and medications. Osteoporosis 1996, 925-946. Academic Press, San Diego (CA). R. Marcus, D. Feldman, J. Relsey (Eds.).
15. Bonadonna S., Mazziotti G., Nuzzo M., et al. Increased prevalence of radiological spinal deformities in active acromegaly: a cross- sectional study in postmenopausal women. J Bone Miner Res 2005, 20:1837-1844.
16. Vestergaard P., Mosekilde L. Fracture risk is devreased in acromegaly: a potential beneficial effect of growth hormone. Osteoporos Int 2004, 15:155-159.